Production (Stage)
Organogenesis Holdings Inc.
ORGO
$3.03
$0.155.21%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -345.58% | -37.77% | 172.35% | -711.57% | -269.72% |
| Total Depreciation and Amortization | -3.66% | 1.02% | 4.86% | 5.71% | -5.67% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 174.13% | -3.68% | -76.90% | 190.08% | -9.93% |
| Change in Net Operating Assets | -205.55% | 51.05% | -83.17% | 63.48% | -680.62% |
| Cash from Operations | -282.27% | 25.78% | 83.52% | 146.62% | -195.74% |
| Capital Expenditure | -7.88% | -30.83% | -36.65% | 15.39% | 33.15% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -7.88% | -30.83% | -36.65% | 15.39% | 33.15% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 99.54% | -3,623.01% | -0.54% | -0.30% | 6.19% |
| Issuance of Common Stock | -97.65% | 21,160.00% | -- | -100.00% | 17,900.00% |
| Repurchase of Common Stock | 92.95% | -- | -- | 95.18% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -106.11% | 2,106.50% | 2.90% | 33.78% | -46.76% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -162.14% | 826.61% | 293.37% | 107.54% | -371.94% |